Clinical Trial Update: A Study of Fostamatinib in Subjects With Impaired Kidney Function [Phase 1]

View source ↗

Summary

Phase 1 study of fostamatinib in subjects with rheumatoid arthritis and renal impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Fostamatinib (fostamatinib)

Snippet

Sponsor: AstraZeneca | Conditions: Rheumatoid Arthritis, Renal Impairment | Phase 1 | Status: COMPLETED